Verve Therapeutics Overview
Verve Therapeutics Target Price
Analysts' 12-month price predictions for VERV.
Share Price
$11.28
Average Target Price
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-03-04 | RBC Capital | $15 |  33% upside |  |
| 2024-11-06 | H.C. WainwrightMitchell Kapoor | $14 | 24.1% upside | |
| 2024-04-03 | BMO CapitalKostas Biliouris | $30 | 166% upside | |
| 2022-12-15 | Goldman Sachs | $13 | 15.2% upside | |